Advertisement
News
Subscribe to MDT Magazine News

UM School of Medicine receives $45 million private donation for celiac research

October 28, 2010 8:32 am | by EurekAlert | Comments

(University of Maryland Medical Center) With a new $45 million private gift from the family of a grateful patient, the University of Maryland School of Medicine is planning to establish the nation's only major research enterprise devoted to the study of autoimmune and inflammatory...

TOPICS:

Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist

October 28, 2010 8:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 28 /- Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects. "We are excited to begin our journey exploring the therapeutic value of AM152, a potentially novel...

TOPICS:

FDA clears ArthroCare suture implant system

October 28, 2010 7:45 am | by The Associated Press | Comments

Medical products maker ArthroCare Corp. said Thursday it received Food and Drug Administration clearance for its Spartan Peek Suture Implant system.The Austin, Texas, company said the system is indicated for use in fixing soft tissue to bone, and it will be used to reattach rotator cuff...

Advertisement

Gaming market reveals changes in MEMS gyroscope competitive landscape

October 28, 2010 7:35 am | by I-Micronews | Comments

As the use of motion sensors in various consumer electronic devices is expanding quickly, the industry competitive landscape is significantly changing. In particular concerning MEMS gyroscopes.

InVivo repays MLSC loan

October 28, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

InVivo Therapeutics Corp., which brought in a $10.5 million investment as part of a reverse merger on Wednesday, has repaid a $567,930 loan from the Massachusetts Life Sciences Center.

Idenix names Renaud to CEO, president roles

October 28, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Idenix Pharmaceuticals Inc. has appointed Ronald C. Renaud, Jr. as president, CEO and board member of the Cambridge biotech, following the resignation of previous president, CEO, chairman and company founder Jean-Pierre Sommadossi.

Country Music Star Teams up with JDRF to Inspire Kids With Diabetes and Raise Money for Research

October 28, 2010 7:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 28 /- In honor of November's Diabetes Awareness Month and World Diabetes Day 2010 (November 14), George Canyon , country music recording artist and Nashville Star finalist, will release his current Canadian hit single, "I Believe in Angels" in the U.S. and offer a special...

TOPICS:

Zimmer 3Q profit jumps on lower costs

October 28, 2010 6:45 am | by The Associated Press | Comments

Orthopedic implant maker Zimmer Holdings Inc. said Thursday its third-quarter profit climbed 27 percent on lower operating expenses.The results beat Wall Street estimates but Zimmer cut its estimate for revenue growth on a constant currency basis for the year and its shares fell almost 4...

Advertisement

Accuray Hires General Manager for the Asia Pacific Region

October 28, 2010 6:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 28 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that Bob Wong has returned to Accuray as General Manager of the APAC (Asia Pacific, including Australia but excluding India and Japan) region effective October...

TOPICS:

New Orthopedic Market Research Data Covering Multiple Geographies Released by Millennium Research Group

October 28, 2010 6:33 am | by Bio-Medicine.Org | Comments

TORONTO, Oct. 28 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest orthopedics research data including information for multiple geographies on orthopedic biomaterials, reconstructive implants, and orthopedic...

TOPICS:

CyberKnife Center of Miami Lends a Hand in Treatment of Haitian Nurse

October 28, 2010 6:33 am | by Bio-Medicine.Org | Comments

MIAMI, Oct. 28 /- Who would've guessed that among all the tragic injuries and infectious disease resulting from Haiti's earthquake that a brain tumor patient would be treated along the way? The CyberKnife Center of Miami is helping out by donating the treatment, care, lodging and expenses...

TOPICS:

Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call

October 28, 2010 6:32 am | by Bio-Medicine.Org | Comments

CARY, N.C., Oct. 28 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today announced that it will host a conference call at 4:30 PM ET on Thursday, November 4, 2010, to discuss its financial results for the quarter and nine months ended September 30, 2010. Financial results are expected...

TOPICS:

Why it makes sense to consult ER patients before sending them to CT

October 28, 2010 6:31 am | by Diagnostic Imaging | Comments

It’s all too easy to reduce medicine to facts, practices to technology. Patients need to be consulted when it comes to making decisions involving the use of CT, according to a recent emergency room survey, even when time is in short supply and the answers seem obvious.

TOPICS:

Integra LifeSciences 3Q profit rises 14.6 percent

October 28, 2010 5:45 am | by The Associated Press | Comments

Medical device maker Integra LifeSciences Holdings Corp. said Thursday its third-quarter profit grew 14.6 percent, led by an increase in orthopedic sales.The company said its profit rose to $16.5 million, or 55 cents per share, from $14.4 million, or 49 cents per share, during the same period a...

Glaucoma therapy firm Solx takes in $3.7M

October 28, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Solx Inc., the Sudbury maker of a laser treatment for glaucoma, has raised $3.7 million in a new round of equity financing, the company reports in a regulatory filing posted yesterday.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading